al-38583

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2009 (NCT00881673)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • al38583
  • al-38583

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01001091Phase 2Dec 1, 2009Alcon, ORA, Inc.
NCT00893139Phase 2Jun 1, 2009Alcon
NCT00881673Phase 2May 1, 2009Alcon
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AlconFor profit3312009
ORA, Inc.For profit1012009
2 organizations
Page 1 / 1